Slimrchat
Slimrchat, operating as Commercial Intelligence, provides SCG Insight, a platform that tracks live pricing for GLP-1 medications Wegovy and Mounjaro across 100+ UK providers. The service consolidates pricing, market position, and movement into a single dashboard, eliminating manual price checks. Access is restricted to named accounts approved by the company.
- Data & Analytics
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Healthcare stakeholders tracking GLP-1 medications such as Wegovy and Mounjaro face fragmented and outdated pricing information, requiring time-consuming manual price checks across numerous providers. This slows decision-making and prevents timely responses to market fluctuations.
Solution
Commercial Intelligence offers SCG Insight, a dedicated platform that tracks the UK weight-loss market across over 100 providers for Wegovy and Mounjaro. The service consolidates live pricing data, market position, and movement into a single view, enabling users to monitor cost fluctuations in real time. By automating price tracking, the platform frees users from manual checks, allowing them to focus on strategy and action based on current market intelligence. Access is restricted to named accounts approved by the company, ensuring data is shared only with verified stakeholders.
Target Audience
Primary users are healthcare stakeholders, including providers, payers, and industry analysts in the UK who need current GLP-1 pricing intelligence to inform purchasing and market strategy decisions.
Features
- Live pricing data for GLP-1 medications Wegovy and Mounjaro across 100+ UK providers
- Real-time market position and movement tracking in one centralized dashboard
- Named-account access control for secure, vetted distribution of market intelligence
- Automated price monitoring that eliminates manual price-check workflows